192 related articles for article (PubMed ID: 38356704)
1. Programmed cell death-index (PCDi) as a prognostic biomarker and predictor of drug sensitivity in cervical cancer: a machine learning-based analysis of mRNA signatures.
Wang W; Chen P; Yuan S
J Cancer; 2024; 15(5):1378-1396. PubMed ID: 38356704
[No Abstract] [Full Text] [Related]
2. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
[TBL] [Abstract][Full Text] [Related]
3. Identifying the programmed cell death index of hepatocellular carcinoma for prognosis and therapy response improvement by machine learning: a bioinformatics analysis and experimental validation.
Shi Y; Feng Y; Qiu P; Zhao K; Li X; Deng Z; Wang J
Front Immunol; 2023; 14():1298290. PubMed ID: 38170006
[TBL] [Abstract][Full Text] [Related]
4. Leveraging diverse cell-death related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma.
Wu Z; Jin M; Xin P; Zhang H
Front Immunol; 2023; 14():1293729. PubMed ID: 38146369
[TBL] [Abstract][Full Text] [Related]
5. Machine learning reveals diverse cell death patterns in lung adenocarcinoma prognosis and therapy.
Wang S; Wang R; Hu D; Zhang C; Cao P; Huang J
NPJ Precis Oncol; 2024 Feb; 8(1):49. PubMed ID: 38409471
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic role and immune correlates of programmed cell death-related genes in hepatocellular carcinoma.
He Z; Zhang J; Huang W
Sci Rep; 2023 Nov; 13(1):20509. PubMed ID: 37993470
[TBL] [Abstract][Full Text] [Related]
7. Integration of machine learning for developing a prognostic signature related to programmed cell death in colorectal cancer.
Xu QT; Qiang JK; Huang ZY; Jiang WJ; Cui XM; Hu RH; Wang T; Yi XL; Li JY; Yu Z; Zhang S; Du T; Liu J; Jiang XH
Environ Toxicol; 2024 May; 39(5):2908-2926. PubMed ID: 38299230
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
[TBL] [Abstract][Full Text] [Related]
9. Multiple programmed cell death patterns and immune landscapes in bladder cancer: Evidence based on machine learning and multi-cohorts.
Li Z; Li Y; Liu L; Zhang C; Li X
Environ Toxicol; 2024 Mar; 39(3):1780-1801. PubMed ID: 38064272
[TBL] [Abstract][Full Text] [Related]
10. Targeting PRKDC activates the efficacy of antitumor immunity while sensitizing chemotherapy and targeted therapy in liver hepatocellular carcinoma.
Pan Y; Zhu Q; Hong T; Cheng J; Tang X
Aging (Albany NY); 2024 May; 16():. PubMed ID: 38787389
[TBL] [Abstract][Full Text] [Related]
11. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery.
Zou Y; Xie J; Zheng S; Liu W; Tang Y; Tian W; Deng X; Wu L; Zhang Y; Wong CW; Tan D; Liu Q; Xie X
Int J Surg; 2022 Nov; 107():106936. PubMed ID: 36341760
[TBL] [Abstract][Full Text] [Related]
12. Identification an innovative classification and nomogram for predicting the prognosis of thyroid carcinoma patients and providing therapeutic schedules.
Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14817-14831. PubMed ID: 37596371
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicineĀ and based on a 101-combination machine learning computational framework.
Liu J; Shi Y; Zhang Y
EPMA J; 2023 Jun; 14(2):275-305. PubMed ID: 37275552
[TBL] [Abstract][Full Text] [Related]
14. A novel natural killer cell-related signatures to predict prognosis and chemotherapy response of pancreatic cancer patients.
Lan Y; Jia Q; Feng M; Zhao P; Zhu M
Front Genet; 2023; 14():1100020. PubMed ID: 37035749
[No Abstract] [Full Text] [Related]
15. Integrated bioinformatic analysis identified a novel prognostic pan-programmed cell death signature for bladder cancer.
Zhang L; Peng M
Front Immunol; 2022; 13():1030097. PubMed ID: 36505448
[TBL] [Abstract][Full Text] [Related]
16. Metal-dependent programmed cell death-related lncRNA prognostic signatures and natural drug sensitivity prediction for gastric cancer.
Song X; Hou L; Zhao Y; Guan Q; Li Z
Front Pharmacol; 2022; 13():1039499. PubMed ID: 36339625
[No Abstract] [Full Text] [Related]
17. Comprehensive analysis of diverse programmed cell death patterns in the prognosis, tumor microenvironment and drug sensitivity in hepatocellular carcinoma.
Yu Y; Lou Y; Zhu J; Wang X
Medicine (Baltimore); 2023 Dec; 102(48):e36239. PubMed ID: 38050240
[TBL] [Abstract][Full Text] [Related]
18. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
19. A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma.
Zhang Y; Wang Y; Chen J; Xia Y; Huang Y
Front Immunol; 2023; 14():1183230. PubMed ID: 37671155
[TBL] [Abstract][Full Text] [Related]
20. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]